CDC45

cell division cycle 45, the group of CMG helicase complex

Basic information

Region (hg38): 22:19479457-19520612

Previous symbols: [ "CDC45L2", "CDC45L" ]

Links

ENSG00000093009NCBI:8318OMIM:603465HGNC:1739Uniprot:O75419AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Meier-Gorlin syndrome 7 (Strong), mode of inheritance: AR
  • Meier-Gorlin syndrome 7 (Strong), mode of inheritance: AR
  • Meier-Gorlin syndrome (Supportive), mode of inheritance: AD
  • Meier-Gorlin syndrome 7 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Meier-Gorlin syndrome 7ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Gastrointestinal; Musculoskeletal; Neurologic27374770

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CDC45 gene.

  • not provided (8 variants)
  • Meier-Gorlin syndrome 7 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC45 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
37
clinvar
6
clinvar
46
missense
5
clinvar
81
clinvar
6
clinvar
1
clinvar
93
nonsense
2
clinvar
1
clinvar
3
start loss
1
clinvar
1
frameshift
7
clinvar
7
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
6
15
1
23
non coding
1
clinvar
7
clinvar
61
clinvar
29
clinvar
98
Total 9 7 93 104 36

Variants in CDC45

This is a list of pathogenic ClinVar variants found in the CDC45 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
22-19479706-T-G Likely benign (Apr 20, 2019)1223417
22-19479774-C-G Benign (Nov 10, 2018)1249527
22-19479837-G-A Likely benign (Mar 31, 2019)1201636
22-19479939-G-T Benign (Oct 31, 2018)1252951
22-19479969-A-C Uncertain significance (Nov 28, 2022)1373437
22-19479972-T-A Uncertain significance (Jul 12, 2022)1488398
22-19479980-C-A Uncertain significance (Jun 01, 2021)1358237
22-19479987-C-G Conflicting classifications of pathogenicity (Jan 08, 2024)809317
22-19479992-A-G Likely benign (Jun 24, 2022)1925672
22-19480009-T-C Inborn genetic diseases Uncertain significance (Dec 13, 2022)1511081
22-19480024-C-T Uncertain significance (May 04, 2022)1922118
22-19480027-C-T Likely benign (Apr 25, 2021)1644039
22-19480030-G-A Likely benign (Aug 23, 2022)2092230
22-19480129-T-C Benign (Oct 16, 2018)1234967
22-19480146-C-T Likely benign (Jun 05, 2023)1636687
22-19480152-C-T Likely benign (Sep 08, 2020)1078836
22-19480153-G-T Likely benign (Sep 03, 2021)1638092
22-19480156-A-G Likely pathogenic (Mar 18, 2022)2113883
22-19480194-C-T Benign (Jan 29, 2024)1168874
22-19480364-G-A Likely benign (Dec 01, 2018)1212170
22-19480414-G-A Benign (Mar 01, 2020)1286104
22-19480495-AG-A Likely benign (Aug 05, 2019)1219597
22-19480848-C-T Likely benign (Mar 16, 2019)1214640
22-19480940-ACT-A Likely benign (Mar 29, 2023)3015581
22-19480944-T-C Uncertain significance (Apr 06, 2022)1950148

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CDC45protein_codingprotein_codingENST00000437685 1941154
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004621.001257030451257480.000179
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8283153590.8770.00002103991
Missense in Polyphen6794.9770.705441014
Synonymous0.7291291400.9220.000008461091
Loss of Function3.461436.60.3830.00000173410

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001850.000185
Ashkenazi Jewish0.000.00
East Asian0.0007630.000761
Finnish0.000.00
European (Non-Finnish)0.0001590.000158
Middle Eastern0.0007630.000761
South Asian0.0002610.000261
Other0.0003390.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for initiation of chromosomal DNA replication.;
Pathway
Cell cycle - Homo sapiens (human);Cell Cycle;Mitotic G1-G1-S phases;Retinoblastoma (RB) in Cancer;G1 to S cell cycle control;DNA Replication;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Activation of E2F1 target genes at G1/S;G1/S-Specific Transcription;Activation of the pre-replicative complex;Unwinding of DNA;Mitotic G1-G1/S phases;DNA Replication;DNA strand elongation;Synthesis of DNA;S Phase;G1/S Transition;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;Cell Cycle, Mitotic (Consensus)

Recessive Scores

pRec
0.236

Intolerance Scores

loftool
rvis_EVS
-0.27
rvis_percentile_EVS
34.82

Haploinsufficiency Scores

pHI
0.986
hipred
Y
hipred_score
0.800
ghis
0.649

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cdc45
Phenotype
embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;

Gene ontology

Biological process
DNA replication checkpoint;G1/S transition of mitotic cell cycle;regulation of transcription involved in G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;DNA replication;DNA replication initiation;regulation of chromatin silencing at telomere;DNA duplex unwinding;positive regulation of G1/S transition of mitotic cell cycle;mitotic DNA replication preinitiation complex assembly
Cellular component
nucleus;nucleoplasm;nuclear pre-replicative complex;cytoplasm;centrosome;DNA replication preinitiation complex;replication fork protection complex
Molecular function
chromatin binding;DNA replication origin binding;single-stranded DNA binding;protein binding;3'-5' DNA helicase activity